Quality & Regulatory
Quality and regulatory support built in from the start.
InVitria makes recombinant, animal-origin-free proteins for cell culture, biomanufacturing, and final formulation. Our quality system and regulatory documentation are designed to help you qualify a raw material and support your filings from research through commercial production.
Manufacturing
cGMP manufacturing at an ISO 9001:2015 certified facility.
InVitria products are manufactured under a cGMP-compliant quality management system with respect to 21 CFR Parts 210 and 211. Manufacturing takes place at our facility in Junction City, Kansas, USA, certified to ISO 9001:2015 by Amtivo (USA) Inc.
Our recombinant proteins are made on the ExpressTec® platform, in continuous commercial production since 1998.
- 21 CFR 210/211
- cGMP-compliant quality management system
- ISO 9001:2015
- Certified facility in Junction City, Kansas, USA. Certification body: Amtivo (USA) Inc.
- 100% Audit
Success Rate - >50 successful vendor qualification audits including many of the largest pharmaceutical companies in the world.
Animal-origin-free
Animal-origin-free by design.
ExpressTec uses a non-animal production host and eliminates animal and human-derived components. This removes the TSE/BSE risk of bovine serum albumin and the adventitious agent risk and donor variability of plasma-derived albumin.
Free of animal-derived components
Across the entire process.
Raw materials
No animal or human-derived inputs
Production host
Non-animal expression system
Manufacturing equipment
Free of animal-derived components
Product-contact packaging
Free of animal-derived components
Regulatory precedent
Excipient quality with regulatory precedent.
InVitria’s recombinant albumin is an approved excipient in licensed injectable human therapeutics. Optibumin 25, Optibumin 20, and Exbumin are manufactured as excipients, with specifications adhering to excipient standards and tested with consideration to the USP monograph for recombinant albumin. Every lot is released against defined specifications.
Excipient recombinant albumin
Optibumin 25
Optibumin 20
Exbumin
Documentation
Documentation to support your filings.
We provide documentation to support supplier qualification and customer regulatory submissions, including IND, BLA, and comparable global filings.
Every lot
Certificate of Analysis
Issued for every lot, released against defined specifications.
Handling
Safety Data Sheet & Guidelines for Use
Safe-handling information and recommended use conditions for each product.
Origin
Certificate of Origin & Animal-Free / TSE-BSE Statement
Documents the non-animal origin of the product and its manufacturing inputs.
Quality system
ISO 9001 Certificate & cGMP Statement
Evidence of the certified quality management system behind every product.
DMF
Product-Specific Technical Summaries
Drug Master File information on manufacturing, raw material controls, characterization, release specifications, and lot analysis.
Change control
Change Notification
Notification of changes under defined policies, so your qualification stays current.
Supply chain
Reliable supply and traceability.
Recombinant production measured in metric tons of final product per year, from a supply chain owned and managed by InVitria from start to finish, provides controlled and traceable supply. North American orders ship directly from Junction City, Kansas, and European customers receive direct fulfillment from our Rotterdam, Netherlands facility.
Supply commitments and priority allocation are available for strategic programs.
- Metric Ton Capacity
- Controlled and traceable supply
- Junction City, KS
- Direct shipment for North American orders
- Rotterdam, NL
- Direct fulfillment for European customers
Request regulatory documentation
Need a Technical Summary, certificate, or statement for your qualification package?
Contact the InVitria team to request regulatory documentation or talk through your program’s requirements.